2022 Q3 Form 10-Q Financial Statement

#000119983522000477 Filed on August 15, 2022

View on sec.gov

Income Statement

Concept 2022 Q3 2022 Q2 2022 Q1
Revenue $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $10.51K $99.55K $33.48K
YoY Change -75.99% 123.11% -53.25%
% of Gross Profit
Research & Development $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $10.51K $99.55K $33.48K
YoY Change -86.27% 20.24% -67.85%
Operating Profit -$10.51K -$99.55K -$33.48K
YoY Change -86.28% 20.24%
Interest Expense -$1.660K -$240.00 -$440.00
YoY Change -93.45% -99.01% -98.07%
% of Operating Profit
Other Income/Expense, Net -$1.664K $2.187M -$439.00
YoY Change -9114.64%
Pretax Income -$12.17K $2.087M -$33.92K
YoY Change -88.06% -2049.69% -73.27%
Income Tax
% Of Pretax Income
Net Earnings -$12.17K $2.087M -$33.92K
YoY Change -88.06% -2049.78% -73.27%
Net Earnings / Revenue
Basic Earnings Per Share
Diluted Earnings Per Share -$100.60 $36.24K -$669.90
COMMON SHARES
Basic Shares Outstanding 120.9M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2022 Q3 2022 Q2 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $4.210K $560.00 $1.040K
YoY Change -62.71% -95.87% -95.13%
Cash & Equivalents $4.211K $561.00 $1.039K
Short-Term Investments
Other Short-Term Assets $270.00 $270.00 $270.00
YoY Change -81.25% -93.22% -93.18%
Inventory
Prepaid Expenses $273.00 $273.00
Receivables
Other Receivables
Total Short-Term Assets $4.484K $834.00 $1.310K
YoY Change -64.78% -95.24% -94.82%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets $0.00 $0.00 $0.00
YoY Change -100.0% -100.0% -100.0%
TOTAL ASSETS
Total Short-Term Assets $4.484K $834.00 $1.310K
Total Long-Term Assets $0.00 $0.00 $0.00
Total Assets $4.484K $834.00 $1.310K
YoY Change -98.15% -99.66% -99.49%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $12.56K $4.340K $203.4K
YoY Change -92.48% -96.86% 53.08%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $8.320K $720.00 $57.41K
YoY Change -99.63% -99.97% -97.28%
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $20.88K $5.059K $260.8K
YoY Change -99.14% -99.78% -88.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities $0.00 $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $20.88K $5.059K $260.8K
Total Long-Term Liabilities $0.00 $0.00 $0.00
Total Liabilities $20.88K $5.060K $260.8K
YoY Change -99.14% -99.78% -88.36%
SHAREHOLDERS EQUITY
Retained Earnings -$4.253M -$4.241M
YoY Change
Common Stock $4.237M $4.237M
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity -$16.39K -$4.225K -$259.5K
YoY Change
Total Liabilities & Shareholders Equity $4.484K $834.00 $1.310K
YoY Change -98.15% -99.66% -99.49%

Cashflow Statement

Concept 2022 Q3 2022 Q2 2022 Q1
OPERATING ACTIVITIES
Net Income -$12.17K $2.087M -$33.92K
YoY Change -88.06% -2049.78% -73.27%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$3.350K -$42.79K -$14.97K
YoY Change -72.68% 13.23% 137.62%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 7.000K 42.32K 10.00K
YoY Change -30.0% 41.07% -33.33%
NET CHANGE
Cash From Operating Activities -3.350K -42.79K -14.97K
Cash From Investing Activities
Cash From Financing Activities 7.000K 42.32K 10.00K
Net Change In Cash 3.650K -470.0 -4.970K
YoY Change -261.5% -93.97% -157.13%
FREE CASH FLOW
Cash From Operating Activities -$3.350K -$42.79K -$14.97K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
dei Entity Central Index Key
EntityCentralIndexKey
0001319643
dei Amendment Flag
AmendmentFlag
false
dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q2
dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
CY2021Q2 lsmg Rescinded Sapir Transaction
RescindedSapirTransaction
usd
lsmg Rescinded Sapir Transaction
RescindedSapirTransaction
usd
lsmg Rescinded Sapir Transaction
RescindedSapirTransaction
usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Interest Paid Net
InterestPaidNet
usd
us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
usd
lsmg Reinstated Debt
ReinstatedDebt
usd
lsmg Shares Issued To Shareholder To Settle Debt
SharesIssuedToShareholderToSettleDebt
usd
CY2021Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
usd
CY2022Q2 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0 shares
dei Document Type
DocumentType
10-Q
dei Document Quarterly Report
DocumentQuarterlyReport
true
dei Document Period End Date
DocumentPeriodEndDate
2022-06-30
dei Document Transition Report
DocumentTransitionReport
false
dei Entity File Number
EntityFileNumber
000-53676
dei Entity Registrant Name
EntityRegistrantName
LODE-STAR MINING INC.
dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NV
dei Entity Tax Identification Number
EntityTaxIdentificationNumber
47-4347638
dei Entity Address Address Line1
EntityAddressAddressLine1
1 East Liberty Street
dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 600
dei Entity Address City Or Town
EntityAddressCityOrTown
Reno
dei Entity Address State Or Province
EntityAddressStateOrProvince
NV
dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
89501
dei City Area Code
CityAreaCode
(775)
dei Local Phone Number
LocalPhoneNumber
234-5443
dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
dei Entity Small Business
EntitySmallBusiness
true
dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
dei Entity Shell Company
EntityShellCompany
false
CY2022Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
120937442 shares
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
561 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6008 usd
CY2022Q2 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
273 usd
CY2021Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
273 usd
CY2022Q2 us-gaap Assets Current
AssetsCurrent
834 usd
CY2021Q4 us-gaap Assets Current
AssetsCurrent
6281 usd
CY2022Q2 us-gaap Assets
Assets
834 usd
CY2021Q4 us-gaap Assets
Assets
6281 usd
CY2022Q2 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
4339 usd
CY2021Q4 us-gaap Accounts Payable And Accrued Liabilities Current
AccountsPayableAndAccruedLiabilitiesCurrent
190394 usd
CY2022Q2 lsmg Due To Related Parties And Accrued Interest Current
DueToRelatedPartiesAndAccruedInterestCurrent
720 usd
CY2021Q4 lsmg Due To Related Parties And Accrued Interest Current
DueToRelatedPartiesAndAccruedInterestCurrent
41473 usd
CY2022Q2 us-gaap Liabilities Current
LiabilitiesCurrent
5059 usd
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
231867 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
480000000 shares
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
480000000 shares
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120937442 shares
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
50634536 shares
CY2022Q2 us-gaap Common Stock Value
CommonStockValue
73757 usd
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
3454 usd
CY2021Q4 lsmg Shares To Be Issued
SharesToBeIssued
2186917 usd
CY2022Q2 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
4163056 usd
CY2021Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
1632152 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4241038 usd
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4048109 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-4225 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-225586 usd
CY2022Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
834 usd
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
6281 usd
CY2022Q2 lsmg Consulting Services
ConsultingServices
52074 usd
CY2021Q2 lsmg Consulting Services
ConsultingServices
31387 usd
lsmg Consulting Services
ConsultingServices
58295 usd
lsmg Consulting Services
ConsultingServices
62575 usd
CY2022Q2 lsmg Corporate Support Services
CorporateSupportServices
503 usd
CY2021Q2 lsmg Corporate Support Services
CorporateSupportServices
512 usd
lsmg Corporate Support Services
CorporateSupportServices
1002 usd
lsmg Corporate Support Services
CorporateSupportServices
1007 usd
CY2021Q2 us-gaap Exploration Expense
ExplorationExpense
13158 usd
us-gaap Exploration Expense
ExplorationExpense
20689 usd
CY2021Q2 us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
25012 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
49988 usd
CY2022Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
-5665 usd
CY2021Q2 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
2769 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
-3929 usd
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4153 usd
CY2022Q2 us-gaap Professional Fees
ProfessionalFees
45164 usd
CY2021Q2 us-gaap Professional Fees
ProfessionalFees
7953 usd
us-gaap Professional Fees
ProfessionalFees
52254 usd
us-gaap Professional Fees
ProfessionalFees
27784 usd
CY2022Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
7469 usd
CY2021Q2 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
1997 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
25271 usd
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
20722 usd
CY2022Q2 us-gaap Costs And Expenses
CostsAndExpenses
99545 usd
CY2021Q2 us-gaap Costs And Expenses
CostsAndExpenses
82788 usd
us-gaap Costs And Expenses
CostsAndExpenses
132893 usd
us-gaap Costs And Expenses
CostsAndExpenses
186918 usd
CY2022Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-99545 usd
CY2021Q2 us-gaap Operating Income Loss
OperatingIncomeLoss
-82788 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-132893 usd
us-gaap Operating Income Loss
OperatingIncomeLoss
-186918 usd
CY2022Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
235 usd
CY2021Q2 us-gaap Interest And Debt Expense
InterestAndDebtExpense
24257 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
807 usd
us-gaap Interest And Debt Expense
InterestAndDebtExpense
47007 usd
CY2022Q2 lsmg Rescinded Sapir Transaction
RescindedSapirTransaction
-2186917 usd
lsmg Rescinded Sapir Transaction
RescindedSapirTransaction
-2186917 usd
CY2022Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2186682 usd
CY2021Q2 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-24257 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2186110 usd
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-47007 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2087137 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-107045 usd
us-gaap Net Income Loss
NetIncomeLoss
2053217 usd
us-gaap Net Income Loss
NetIncomeLoss
-233925 usd
CY2022Q2 lsmg Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0.02
CY2021Q2 lsmg Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.00
lsmg Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
0.02
lsmg Earnings Per Share Basic And Diluted1
EarningsPerShareBasicAndDiluted1
-0.00
CY2022Q2 lsmg Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
57587571 shares
CY2021Q2 lsmg Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
50634536 shares
lsmg Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
54130261 shares
lsmg Weighted Average Number Of Share Outstanding Basic And Diluted1
WeightedAverageNumberOfShareOutstandingBasicAndDiluted1
50624591 shares
us-gaap Net Income Loss
NetIncomeLoss
2053217 usd
us-gaap Net Income Loss
NetIncomeLoss
-233925 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1050 usd
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
84 usd
lsmg Rescinded Sapir Transaction
RescindedSapirTransaction
-2186917 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
73749 usd
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
93134 usd
us-gaap Increase Decrease In Other Accrued Liabilities
IncreaseDecreaseInOtherAccruedLiabilities
49988 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1139 usd
us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
46625 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-57762 usd
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-44094 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
52315 usd
us-gaap Proceeds From Related Party Debt
ProceedsFromRelatedPartyDebt
45000 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
52315 usd
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
45000 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-5447 usd
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
906 usd
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
6008 usd
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12644 usd
CY2022Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
561 usd
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13550 usd
lsmg Expenses Paid By Related Party On Behalf Of Company
ExpensesPaidByRelatedPartyOnBehalfOfCompany
24025 usd
lsmg Expenses Paid By Related Party On Behalf Of Company
ExpensesPaidByRelatedPartyOnBehalfOfCompany
39052 usd
lsmg Reinstated Debt
ReinstatedDebt
2246146 usd
lsmg Shares Issued To Shareholder To Settle Debt
SharesIssuedToShareholderToSettleDebt
2601207 usd
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
-225586 usd
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-33920 usd
CY2022Q1 us-gaap Stockholders Equity
StockholdersEquity
-259506 usd
CY2022Q2 lsmg Rescinded Sapir Transaction
RescindedSapirTransaction
-2186917 usd
CY2022Q2 lsmg Reinstated Debt
ReinstatedDebt
-2246146 usd
CY2022Q2 lsmg Shares Issued To Shareholder To Settle Debt
SharesIssuedToShareholderToSettleDebt
2601207 usd
CY2022Q2 us-gaap Net Income Loss
NetIncomeLoss
2087137 usd
CY2022Q2 us-gaap Stockholders Equity
StockholdersEquity
-4225 usd
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
-1859295 usd
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-126880 usd
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
-1986175 usd
CY2021Q2 us-gaap Net Income Loss
NetIncomeLoss
-107045 usd
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
-2093220 usd
CY2022Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-4241038 usd
us-gaap Basis Of Accounting
BasisOfAccounting
<p id="xdx_849_eus-gaap--BasisOfAccounting_zhXKr4G1rOl7" style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"><b><span id="xdx_86A_zk8wWr1ybmkh">Basis of Presentation</span></b></span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt"> </span></p> <p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><span style="font-family: Times New Roman, Times, Serif; font-size: 10pt">The unaudited interim financial information furnished herein reflects all adjustments which, in the opinion of management, are necessary to fairly state the Company’s financial position and the results of its operations for the periods presented. These financial statements should be read in conjunction with the Company’s financial statements and notes thereto included in the Company’s report on Form 10-K for the year ended December 31, 2021. The Company assumes that the users of the interim financial information herein have read, or have access to, the audited financial statements for the year ended December 31, 2021, and that the adequacy of additional disclosure needed for a fair presentation may be determined in that context. Accordingly, certain footnote disclosures, which would substantially duplicate the disclosures contained in the Company’s financial statements for the fiscal year ended December 31, 2021, have been omitted. The results of operations for the three and six months ended June 30, 2022 are not necessarily indicative of results for the entire year ending December 31, 2022.</span></p>
us-gaap Research And Development In Process
ResearchAndDevelopmentInProcess
2186917 usd
CY2022Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
480000000 shares
CY2022Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000 shares
CY2022Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.001
CY2022Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
120937442 shares
CY2022Q2 lsmg Shares Issued To Shareholder To Settle Debt
SharesIssuedToShareholderToSettleDebt
2601207 usd
lsmg Disclosure Capital Stock Details Abstract
DisclosureCapitalStockDetailsAbstract
<table cellpadding="0" cellspacing="0" id="xdx_880_ecustom--DisclosureCapitalStockDetailsAbstract_z5DCfTaRR2I9" style="font: 10pt Times New Roman, Times, Serif; border-collapse: collapse; width: 70%" summary="xdx: Disclosure - CAPITAL STOCK (Details)"> <tr style="vertical-align: bottom"> <td style="border-bottom: Black 1pt solid; padding-left: 8.65pt; white-space: nowrap; text-align: center; text-indent: -8.65pt"> </td><td style="border-bottom: Black 1pt solid"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Options <br/> Outstanding</td><td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Weighted Average<br/> Life Remaining<br/> (Years)</td><td style="border-bottom: Black 1pt solid"> </td><td style="border-bottom: Black 1pt solid"> </td> <td colspan="2" style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: center">Intrinsic Value</td><td style="border-bottom: Black 1pt solid"> </td></tr> <tr style="vertical-align: bottom"> <td style="padding-left: 8.65pt; white-space: nowrap; text-indent: -8.65pt"> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: right"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center"> </td><td> </td><td> </td> <td colspan="2" style="white-space: nowrap; text-align: center"> </td><td> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="text-indent: -8.65pt; width: 31%; padding-left: 8.65pt">Balance December 31, 2021</td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_985_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iS_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z9OUL2UTjS2l" style="width: 8%; text-align: right">9,950,000</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left"> </td><td id="xdx_98F_eus-gaap--SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2_dxH_c20210101__20211231__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_z19GO1JEFh96" style="width: 8%; text-align: right" title="::XDX::P2M12D">0.20</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td><td style="width: 3%"> </td> <td style="width: 1%; text-align: left">$</td><td id="xdx_987_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iS_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zD54ElfnS18a" style="width: 8%; text-align: right">348,250</td><td style="white-space: nowrap; width: 1%; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: White"> <td style="text-indent: -8.65pt; padding-bottom: 1pt; padding-left: 8.65pt">Expired</td><td style="padding-bottom: 1pt"> </td> <td style="padding-bottom: 1pt; text-align: left"> </td><td id="xdx_981_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod_iN_di_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zLpubyPANVAi" style="border-bottom: Black 1pt solid; text-align: right">(9,950,000</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left">)</td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td><td style="border-bottom: Black 1pt solid"> </td> <td style="border-bottom: Black 1pt solid; text-align: left"> </td><td style="border-bottom: Black 1pt solid; text-align: right"> </td><td style="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204,238,255)"> <td style="border-bottom: Black 1pt solid; text-indent: -8.65pt; font-weight: bold; padding-left: 8.65pt">Balance June 30, 2022</td><td style="border-bottom: Black 1pt solid; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_iE_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zZbbMLJ2uSpf" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0389">-</span></td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right">-</td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"> </td><td style="border-bottom: Black 1pt solid; font-weight: bold"> </td> <td style="border-bottom: Black 1pt solid; font-weight: bold; text-align: left">$</td><td id="xdx_984_eus-gaap--ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue_iE_c20220101__20220630__us-gaap--DerivativeInstrumentRiskAxis__us-gaap--StockOptionMember_zT1iHGd2fjfj" style="border-bottom: Black 1pt solid; font-weight: bold; text-align: right"><span style="-sec-ix-hidden: xdx2ixbrl0390">-</span></td><td style="border-bottom: Black 1pt solid; white-space: nowrap; font-weight: bold; text-align: left"> </td></tr> </table>
us-gaap Foreign Currency Transaction Gain Loss Before Tax
ForeignCurrencyTransactionGainLossBeforeTax
1050 usd

Files In Submission

Name View Source Status
0001199835-22-000477-index-headers.html Edgar Link pending
0001199835-22-000477-index.html Edgar Link pending
0001199835-22-000477.txt Edgar Link pending
0001199835-22-000477-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
lsmg-10q.htm Edgar Link pending
lsmg-20220630.xsd Edgar Link pending
lsmg-ex31_1.htm Edgar Link pending
lsmg-ex32_1.htm Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R3.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
lsmg-20220630_def.xml Edgar Link unprocessable
lsmg-20220630_cal.xml Edgar Link unprocessable
lsmg-20220630_lab.xml Edgar Link unprocessable
lsmg-20220630_pre.xml Edgar Link unprocessable
lsmg-10q_htm.xml Edgar Link completed
Show.js Edgar Link pending